<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
	<id>https://wiki.beaconcancer.org/index.php?action=history&amp;feed=atom&amp;title=MET</id>
	<title>MET - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://wiki.beaconcancer.org/index.php?action=history&amp;feed=atom&amp;title=MET"/>
	<link rel="alternate" type="text/html" href="https://wiki.beaconcancer.org/index.php?title=MET&amp;action=history"/>
	<updated>2026-10-17T03:41:04Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.39.5</generator>
	<entry>
		<id>https://wiki.beaconcancer.org/index.php?title=MET&amp;diff=22007&amp;oldid=prev</id>
		<title>Victor at 14:23, 27 August 2024</title>
		<link rel="alternate" type="text/html" href="https://wiki.beaconcancer.org/index.php?title=MET&amp;diff=22007&amp;oldid=prev"/>
		<updated>2024-08-27T14:23:24Z</updated>

		<summary type="html">&lt;p&gt;&lt;/p&gt;
&lt;table style=&quot;background-color: #fff; color: #202122;&quot; data-mw=&quot;interface&quot;&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;tr class=&quot;diff-title&quot; lang=&quot;en&quot;&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;← Older revision&lt;/td&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;Revision as of 14:23, 27 August 2024&lt;/td&gt;
				&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot; id=&quot;mw-diff-left-l1&quot;&gt;Line 1:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 1:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;MET is a gene that encodes for a receptor tyrosine kinase known as hepatocyte growth factor receptor (HGFR). This protein plays a crucial role in cell growth, survival, and regeneration. Abnormal activation of MET, through mutations, amplifications, or overexpression, is associated with various cancers, including non-small cell lung cancer, renal cell carcinoma, and gastric cancer. Such alterations can lead to uncontrolled cell proliferation and metastasis. Detecting MET abnormalities in &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;tumors &lt;/del&gt;is essential for guiding targeted therapy, as MET inhibitors can block the aberrant signaling pathways, effectively slowing or stopping &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;tumor &lt;/del&gt;growth. Understanding MET&amp;#039;s role in cancer biology allows for personalized treatment strategies, offering improved outcomes and tailored therapies for patients with MET-driven cancers.&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;MET is a gene that encodes for a receptor tyrosine kinase known as hepatocyte growth factor receptor (HGFR). This protein plays a crucial role in cell growth, survival, and regeneration. Abnormal activation of MET, through mutations, amplifications, or overexpression, is associated with various cancers, including non-small cell lung cancer, renal cell carcinoma, and gastric cancer. Such alterations can lead to uncontrolled cell proliferation and metastasis. Detecting MET abnormalities in &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;tumours &lt;/ins&gt;is essential for guiding targeted therapy, as MET inhibitors can block the aberrant signaling pathways, effectively slowing or stopping &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;tumour &lt;/ins&gt;growth. Understanding MET&amp;#039;s role in cancer biology allows for personalized treatment strategies, offering improved outcomes and tailored therapies for patients with MET-driven cancers.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</summary>
		<author><name>Victor</name></author>
	</entry>
	<entry>
		<id>https://wiki.beaconcancer.org/index.php?title=MET&amp;diff=18052&amp;oldid=prev</id>
		<title>Victor: Created page with &quot;MET is a gene that encodes for a receptor tyrosine kinase known as hepatocyte growth factor receptor (HGFR). This protein plays a crucial role in cell growth, survival, and regeneration. Abnormal activation of MET, through mutations, amplifications, or overexpression, is associated with various cancers, including non-small cell lung cancer, renal cell carcinoma, and gastric cancer. Such alterations can lead to uncontrolled cell proliferation and metastasis. Detecting MET...&quot;</title>
		<link rel="alternate" type="text/html" href="https://wiki.beaconcancer.org/index.php?title=MET&amp;diff=18052&amp;oldid=prev"/>
		<updated>2024-05-21T18:05:18Z</updated>

		<summary type="html">&lt;p&gt;Created page with &amp;quot;MET is a gene that encodes for a receptor tyrosine kinase known as hepatocyte growth factor receptor (HGFR). This protein plays a crucial role in cell growth, survival, and regeneration. Abnormal activation of MET, through mutations, amplifications, or overexpression, is associated with various cancers, including non-small cell lung cancer, renal cell carcinoma, and gastric cancer. Such alterations can lead to uncontrolled cell proliferation and metastasis. Detecting MET...&amp;quot;&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;MET is a gene that encodes for a receptor tyrosine kinase known as hepatocyte growth factor receptor (HGFR). This protein plays a crucial role in cell growth, survival, and regeneration. Abnormal activation of MET, through mutations, amplifications, or overexpression, is associated with various cancers, including non-small cell lung cancer, renal cell carcinoma, and gastric cancer. Such alterations can lead to uncontrolled cell proliferation and metastasis. Detecting MET abnormalities in tumors is essential for guiding targeted therapy, as MET inhibitors can block the aberrant signaling pathways, effectively slowing or stopping tumor growth. Understanding MET&amp;#039;s role in cancer biology allows for personalized treatment strategies, offering improved outcomes and tailored therapies for patients with MET-driven cancers.&lt;/div&gt;</summary>
		<author><name>Victor</name></author>
	</entry>
</feed>